Xcelerate(OTC) XCRT

Market Cap$6.00M

Since IPO (2005)-98%

5 Year-87%

1 Year-11%

1 Month+25%

$0.01

+10.40%

+0.00Today

Xcelerate last closing stock price
Metric	Price	Date
Last close	USD 0.01	2026-08-14

Xcelerate stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0.93%	USD 0.01	2026-08-07
1 month	+25.45%	USD 0.01	2026-07-15
3 month	+33.98%	USD 0.01	2026-05-15
Year to date	+57.71%	USD 0.01	2025-12-31
1 year	-11.11%	USD 0.02	2025-08-14
3 year	-84.07%	USD 0.09	2023-08-15
5 year	-87.39%	USD 0.11	2021-08-13
Since inception	-98.03%	USD 0.70	2005-01-25

Xcelerate Financials at a Glance

Market Cap

$6.00M

Revenue (TTM)

-$1.18M

Net Income (TTM)

-$996.57K

EPS (TTM)

$0.00

P/E Ratio

-2.12

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$0.01

Volume

35,000

Open

$0.01

Price

$0.01

Volume

35,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.02

Estimated Earnings Date

May 13, 2026

Dividend

$0.00

Beta (Volatility)

0.46 (Low)

Price

$0.01

Volume

35,000

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.02

Estimated Earnings Date

May 13, 2026

XCRT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Xcelerate

Xcelerate Inc. specializes in sourcing and integrating engineering expertise and patents for nascent medical technology ventures. The company applies its offerings within regulated clinical settings for rigorous evaluation and real-world implementation. Established in 1996, Xcelerate Inc. is based in Mauldin, South Carolina.

Products and Services

Integration of engineering expertise into medical technology
Deployment of technology in clinical settings for validation
Comprehensive approach to medical technology creation

Growth Outlook

Recent quarterly revenue showed a significant increase from previous periods
Strong gross profit margin of 51.2% indicates potential for profitability
Positive net income margin of 1.74% reflects operational efficiency

Financial Highlights

Trailing twelve months (TTM) revenue of $1.5 million
Quarterly net income improved to -$15,630 in Q1 2026
Cash and cash equivalents increased to $328,933 in Q1 2026

Xcelerate Inc. operates in the healthcare sector, focusing on medical technology. The company has shown resilience with a notable gross profit margin, indicating effective cost management and potential for future profitability. The recent quarterly financials reflect a positive trend, with a significant increase in cash reserves, which may support ongoing operations and future growth initiatives. The company's strategic focus on integrating engineering expertise into medical technology positions it well within a growing industry, making it an intriguing option for potential investors.

AI Generated • Jul 20, 2026

Industry

Healthcare Providers and Services

Sector

Health Care

Employees

CEO

Michael F. O'Shea

Website

www.xcelerate.global

Headquarters

Mauldin, SC 29662, US

XCRT Financials

Key Financial Metrics (TTM)

Gross Margin

31.96%

Operating Margin

2.90%

Net Income Margin

84.32%

Return on Equity

53.90%

Return on Capital

N/A

Return on Assets

-454.52%

Earnings Yield

-47.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.00M

Shares Outstanding

434.45M

Volume

35.00K

Avg. Volume

59.88K

Financials (TTM)

Gross Profit

-$377.80K

Operating Income

-$34.30K

EBITDA

-$30.92K

Operating Cash Flow

-$493.49K

Capital Expenditure

$0.00

Free Cash Flow

-$493.49K

Cash & ST Invst.

$204.26K

Total Debt

$1.79M

Xcelerate Performance Analysis

Xcelerate annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 0	N/A
2023	2023-12-31	USD 1,122,085	N/A
2024	2024-12-31	USD 0	N/A
2025	2025-12-31	USD 0	N/A

Xcelerate sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-0.7%
Q4	2025-12-31	-422.2%
Q1	2026-03-31	100.0%
Q2	2026-06-30	N/A

Xcelerate annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.00	175.0%
2023	2023-12-31	USD -0.01	200.0%
2024	2024-12-31	USD -0.00	-63.6%
2025	2025-12-31	USD -0.00	16.7%

Xcelerate sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	100.0%
Q4	2025-12-31	N/A
Q1	2026-03-31	100.0%
Q2	2026-06-30	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$6.00M

N/A

Market Cap/Employee

$499.62K

N/A

Employees

N/A

Net Income

-$32.33K

+80.0%

EBITDA

-$54.18K

+61.0%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$204.26K

+172.0%

Total Debt

$1.79M

-10.4%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

-100.0%

Long Term Debt

$0.00

N/A

Short Term Debt

$1.79M

-10.4%

Return on Assets

-4.55%

N/A

Return on Invested Capital

1.62%

N/A

Free Cash Flow

-$57.68K

-707.2%

Operating Cash Flow

-$57.68K

-707.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BBRRFBlueberries Medical Corp.

BBRRFBlueberries Medical Corp.$0.01+34.62%

PMEDFQscreen Ai Inc.

PMEDFQscreen Ai Inc.$0.02+0.00%

BICXBioCorRx Inc.

BICXBioCorRx Inc.$0.15-45.71%

HLYKHealthLynked Corp.

HLYKHealthLynked Corp.$2.75+0.00%

FAMDFFutura Medical plc

FAMDFFutura Medical plc$0.01+0.00%

KOSKMetawells Oil & Gas Inc.

KOSKMetawells Oil & Gas Inc.$0.00+2.08%

THCBFTHC Biomed Intl Ltd.

THCBFTHC Biomed Intl Ltd.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NUNu Holdings

NUNu Holdings$15.23+0.09%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.76+0.01%

ONDSOndas

ONDSOndas$9.24+0.04%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$140.00-0.01%

INTCIntel

INTCIntel$102.50-0.02%

NVDANvidia

NVDANvidia$225.16-0.00%

NOKNokia

NOKNokia$10.76+0.02%

Questions About XCRT

What is the current price of Xcelerate?

Xcelerate is trading at $0.01 per share.

What is the 52-week range for Xcelerate?

Over the past 52 weeks, Xcelerate has traded between $0.01 and $0.02.

How much debt does Xcelerate have?

As of the most recent reporting period, Xcelerate reported total debt of $1.79M.

How much cash does Xcelerate have on hand?

Xcelerate reported $204.26K in cash and cash equivalents in its most recent financial results.

What is Xcelerate’s dividend yield?

Xcelerate does not currently have a dividend yield.

Xcelerate(OTC) XCRT

Xcelerate Financials at a Glance

XCRT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Xcelerate

XCRT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Xcelerate Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About XCRT

What is the current price of Xcelerate?

What is the 52-week range for Xcelerate?

How much debt does Xcelerate have?

How much cash does Xcelerate have on hand?

What is Xcelerate’s dividend yield?

Premium Investing Services